Premium
Anti‐glaucomatous medication and ocular surface
Author(s) -
Sakellaris Dimitrios
Publication year - 2019
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/j.1755-3768.2019.8121
Subject(s) - glaucoma , medicine , optometry , affect (linguistics) , ophthalmology , compliance (psychology) , glaucoma medication , patient compliance , ocular hypertension , psychology , family medicine , social psychology , communication
The purpose of this talk is to explore the interaction between ocular surface disease (OSD) and anti‐glaucomatous medication, whether a preexisting OSD can affect the success of the anti‐glaucomatous medication in terms of discomfort and non‐compliance and whether the anti‐glaucomatous medication can initiate or worsen OSD.